The FDA has approved GlaxoSmithKline’s Trelegy Ellipta inhaler for asthma in adults ... rival respiratory drugs such as AstraZeneca’s Breztri, which the FDA approved in COPD in July.
Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first ...
Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere ... powder competitor fluticasone-umeclidinium-vilanterol (Trelegy Ellipta) over median follow-ups of 88 and 113 ...